Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
McCreadie Group develops and delivers innovative web-based software solutions that streamline investigational drug service operations and pharmacy residency program management. Their flagship products—Vestigo® and PharmAcademic™—are widely adopted by research institutions, healthcare providers, and academic medical centers to improve efficiency, compliance, safety, and data transparency in clinical trials and pharmacy education. The company was acquired by Cordance in April 2022 to accelerate growth. Recent innovations include bar code validation for investigational drug dispensing in collaboration with major cancer centers. The company transitioned to a fully virtual operation post-pandemic. Sara Brueck Nichols was named President in June 2024.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on McCreadie Group.